Birmingham, West Midlands -- (SBWIRE) -- 01/22/2014 -- Value Penny Stocks issues special report on: Cellceutix Corp(OTCMKTS:CTIX), SCHNEIDER ELECTRIC S(OTCMKTS:SBGSY), Brainstorm Cell Therapeutics Inc(OTCBB:BCLI), Heron Therapeutics Inc(OTCBB:APPAD)
Cellceutix Corp(OTCMKTS:CTIX) managed to keep its gain at 0.99% on above-normal volume of 215,155.00 shares. The stock settled at $1.83, after floating in a range of $1.79 - 1.86. Its latest price has reached market capitalization of $ 216.99M. Its 52-week range has been $1.40 - 2.42. Cellceutix Corporation is an early-stage developmental biopharmaceutical company. The Company has acquired exclusive rights to eight different pharmaceutical compound candidates that are designed for treatment of diseases which exist, or may exist in the future.
Can Investors Bet on CTIX after this News update? Find out in this Research Report
SCHNEIDER ELECTRIC S(OTCMKTS:SBGSY) traded on a volume of 1.85M/74,043.00 Shares, higher than its standard daily volume. Shares have closed at $17.75. Over the last twelve months, the stock faced a worst price of $13.65.
Is SBGSY a Solid Investment at These Levels? Read This Report For Details
Brainstorm Cell Therapeutics Inc(OTCBB:BCLI) settled up at $0.272 on below-normal volume of 2.28M shares during the last trading day. The stock has its 12-month range $ 0.10 - 0.30. It traded in a range of $ 0.23 - 0.30 during the last trading day. BrainStorm Cell Therapeutics Inc. is a biotechnology company developing autologous stem cell therapies for highly debilitating neurodegenerative disorders.
How Should Investors Trade BCLI Now? Don’t Miss out a Special Trend Analysis
In the last trading session, Heron Therapeutics Inc(OTCBB:APPAD) was on high volume, and the ratio between volume of the day versus its average daily volume comes out to be 122,030.00/23,100.00 shares. At $12, the stock has attained market capitalization of 276.52M. Heron Therapeutics Inc, formerly A.P. Pharma, Inc. is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform.
What APPAD Charts Are Signaling for Traders? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)